Recent research has shown that severe cases of COVID-19 show an excessive immune response and a strong cytokine storm, which may include high levels...
Myeloma NZ
Ygalo Shows Positive Response in Triple-refractory Multiple Myeloma Trial
Topline results show a 26% response rate in a Phase 2 clinical trial evaluating Ygalo (melflufen) in patients with triple-refractory multiple...
The squeeze on healthcare in locked-down New Zealand
Medical centres across the country are condensing services, moving online and ushering in pandemic plans. Josie Adams assesses what it’s like to...
Treating COVID-19 in a patient with multiple myeloma
A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill...
Pharmac widens funding for lenalidomide for those with blood cancer
Emma Holden was devastated when she learned she had multiple myeloma. The 31-year-old, who lives in South Canterbury, was diagnosed with the form of...
An open letter to the Prime Minister of New Zealand, Jacinda Ardern
The Patient Voice Aotearoa team, with support from 35 patient advocacy groups, today published a full page ad in the Herald calling on the Prime...
Covid 19 coronavirus: Pharmac eases restrictions on cancer drugs during Covid-19 pandemic
Pharmac will ease restrictions on at least nine cancer drugs, including keytruda for the treatment of advanced melanoma, to reduce hospital visits...
Kiwis with incurable blood cancer set to receive newly reimbursed treatment option
New Zealanders living with the incurable blood cancer, multiple myeloma, are set to gain access to a new treatment option following the decision by...
New drug could reverse treatment resistance in advanced multiple myeloma
Researchers at the VU University Medical Center in the Netherlands have tested a new drug in patient samples and mice with multiple myeloma and...
Article of the week: Managing haematology and oncology patients during the COVID-19 pandemic
Myeloma Australia's Medical and Scientific Advisory Group (MSAG) presents the article of the week. The article from Australia’s National Centre for...
Information About COVID-19 for Myeloma Patients
COVID-19, short for coronavirus disease 2019, is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is...
Coronavirus in NZ: How to self-isolate – Kiwi diagnosed with cancer shares advice
A Kiwi diagnosed with cancer has shared advice on how to self-isolate while living with others and what precautions immunocompromised people should...